CHMP meeting highlights: 22 to 25 June 2026

1st July 2026

Summary: During its meeting from 22nd to 25th June 2026, the CHMP recommended a number of new medicines for marketing authorisation across a range of therapeutic areas, alongside decisions on extensions of indication and changes to existing medicines. The committee also adopted opinions on safety updates, reviewed medicines under evaluation and considered a range of regulatory matters aimed at supporting the availability of safe, effective and high-quality medicines across the European Union. The meeting highlights provide an overview of the committee's latest recommendations before they are considered by the European Commission.

Link: https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-june-2026

Back to Recent News